--- title: Dolomite Bio launches Nadia Go - An affordable microfluidic system for custom protocol development description: This new system from Dolomite Bio, combines the microfluidic technology underlying their Nadia Instrument, with the customisable parameters of the Nadia Innovate. image: https://news.lifesciencenewswire.com/hubfs/Dolomite%20Bio%20scientist%20demonstrating%20pipetting%20into%20the%20Nadia%20Go.png --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Dolomite Bio launches Nadia Go - An affordable microfluidic system for custom protocol development](https://news.lifesciencenewswire.com/newsroom/dolomite-bio-launches-nadia-go-an-affordable-microfluidic-system-for-custom-protocol-development) September 21, 2022 [![Dolomite Bio scientist demonstrating pipetting into the Nadia Go](https://news.lifesciencenewswire.com/hs-fs/hubfs/Dolomite%20Bio%20scientist%20demonstrating%20pipetting%20into%20the%20Nadia%20Go.png?width=262&name=Dolomite%20Bio%20scientist%20demonstrating%20pipetting%20into%20the%20Nadia%20Go.png)](https://drive.google.com/file/d/1L163qx45AIJ5WdMwyadBTHd9hNJY1ULR/view?usp=sharing)A compact, affordable microfluidic system for custom microfluidic and genomics research is launching September 21st. This new system from Dolomite Bio, combines the microfluidic technology underlying their Nadia Instrument, with the customisable parameters of the Nadia Innovate, granting access to the custom microfluidic protocol development without the necessity of large capital outlay. Currently most custom microfluidic research is performed using older complex modular systems. These are notoriously tricky and time consuming to set up, unreliable and require some level of expertise in microfluidics to be effective. In contrast, Nadia Go has a small footprint, no tubing, no PDMS, uses single use chips, and has a semi-automated set up, with parameters controlled through an easy-to-use PC software. In addition to solving the drawbacks of modular systems, Nadia Go is a completely open platform, created with the ‘tinkerers’ in mind. Using Dolomite Bio’s core pressure-controlled microfluidics technology, Nadia Go enables the development of user-defined single cell protocols and applications. Create, change, test and save novel protocols and biological workflows through the adjustment of user defined parameters such as droplet size, droplet frequency, temperature, agitation, and timing. Plus, observe droplet formation in real time with the Nadia Go’s high-speed microscope and camera for easy process visualization. Giving researchers complete freedom from standard protocols and applications, as well as the liberty to create and share novel protocols with other users. Mark Gilligan, the CEO for Dolomite Bio, spoke about the drive behind the Nadia Go launch “We’ve gone further to democratise science by developing the Nadia Go, a cost-effective system making microfluidics accessible to an even greater number of researchers” This unique product is an exciting addition to any lab interested in custom microfluidic research, or to compliment research performed using standardised applications on other instruments for single cell research. Whatever your research goals, you can customize, develop and discover with the Nadia Go. About Dolomite Bio Established in 2016, Dolomite Bio creates innovative products for high throughput single cell research. By encapsulating single cells in microfluidic droplets, its products enable rapid analysis of thousands or millions of individual cells and their biological products. Dolomite Bio’s products include the Nadia Product Family, enabling research in many application areas, such as single cell RNA-Seq, single nuclei RNA-Seq, plant protoplast RNA-Seq, 3D cell culture and the encapsulation of cells in agarose. Dolomite Bio is a brand of Blacktrace Holdings Ltd (est. 2001), a world leader in Productizing Science®. Its Head Office is in Royston (near Cambridge), UK with regional offices in the USA, Japan and Vietnam. To learn more about Dolomite Bio, please visit [www.dolomite-bio.com](http://www.dolomite-bio.com). Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)